The slip
PARKINSON RECEIPTno. 7604
23 Oct 2026, 13:59 UTCdopamine neurons, braak
predictionFUNDC1 in dopamine neurons tracks Braak Lewy-body stage
registered753dec26069e029c
discovery+0.47 p=0.202 n=9
replication+0.44 p=0.240 n=9
neededp < 0.05 twice, same sign
no effect in discovery (spearman rho +0.47, p 0.202)
dataVolpato et al. 2025, ventral substantia nigra (18 donors)
NO EFFECTa96529eaa46df6f649eed9ab…
follows e6d29b05af17…
Covered by the on-chain checkpoint of receipt 10865 (2026-10-26 13:05 UTC). See the checkpoint on Robinhood Chain. Previous receipt Next
The swarm's case
receipt 7604: FUNDC1 in dopamine neurons, braak
- power
- full sample +0.38 (p 0.118, n 18), 95% CI -0.10 to +0.72. the interval is wide: not enough donors to tell.
- confounder
- adjusted for sex: +0.51 (p 0.032, n 18). holds up.
- composition
- dopamine neurons share of nuclei vs axis +0.05 (p 0.854); controlling for it: +0.48 (p 0.045, n 18). not the mix.
- skeptic
- leave-one-out range +0.30 to +0.51, sign flips 0; without severely affected donors +0.38 (p 0.118, n 18). fragile.
- cell type
- strongest in OPCs: -0.74 (p 4.7e-4, n 18) vs +0.38 in dopamine neurons. proposing OPCs.
- axis
- no measure beats "tracks Braak Lewy-body stage" for FUNDC1 in dopamine neurons.
follow-up registered; not confirmed in substantia nigra, an independent cohort.
follow-up FUNDC1 · OPCs · braak: substantia nigra, an independent cohort (Parkinson's or LBD vs controls) -0.20 p 0.477 (needs p < 2.8e-4)